Annual Accounts Receivable
N/A
December 31, 2023
Summary
- XTLB annual accounts receivable is not available.
Performance
XTLB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$140.00 K
NaN%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly accounts receivable is $140.00 thousand
- XTLB quarterly accounts receivable is now -91.60% below its all-time high of $1.67 million, reached on June 30, 2005.
Performance
XTLB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XTLB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
XTLB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | ||
| 5 y | 5-year | at high | at low | ||
| alltime | all time | -91.6% | -100.0% |
XTL Biopharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $140.00 K(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(-100.0%) |
| Sep 2014 | - | $134.00 K(-6.9%) |
| Jun 2014 | - | $144.00 K(+25.2%) |
| Mar 2014 | - | $115.00 K(-8.7%) |
| Dec 2013 | $126.00 K(+65.8%) | $126.00 K(+18.9%) |
| Sep 2013 | - | $106.00 K(+9.3%) |
| Jun 2013 | - | $97.00 K(-2.0%) |
| Mar 2013 | - | $99.00 K(+30.3%) |
| Dec 2012 | $76.00 K | $76.00 K(+52.0%) |
| Sep 2012 | - | $50.00 K(-47.9%) |
| Jun 2012 | - | $96.00 K(+33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $72.00 K(+46.9%) |
| Sep 2011 | - | $49.00 K(-16.9%) |
| Jun 2011 | - | $59.00 K(-35.9%) |
| Mar 2011 | - | $92.00 K(+384.2%) |
| Sep 2010 | - | $19.00 K(0.0%) |
| Jun 2010 | - | $19.00 K(-56.8%) |
| Mar 2010 | - | $44.00 K(+120.0%) |
| Sep 2009 | - | $20.00 K(-94.3%) |
| Dec 2007 | $352.00 K(-18.3%) | $352.00 K(-45.3%) |
| Jun 2006 | - | $644.00 K(+49.4%) |
| Dec 2005 | $431.00 K(-49.2%) | $431.00 K(-74.1%) |
| Jun 2005 | - | $1.67 M(+96.3%) |
| Dec 2004 | $849.00 K | $849.00 K(+21.3%) |
| Jun 2004 | - | $700.00 K |
FAQ
- What is the all time high annual accounts receivable for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for XTL Biopharmaceuticals?
What is the all time high annual accounts receivable for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual accounts receivable is $849.00 K
What is XTL Biopharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of XTLB is $140.00 K
What is the all time high quarterly accounts receivable for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly accounts receivable is $1.67 M